Awaiting development: Guidance and quality standards
Showing 1 to 4 of 4
| Title | Type |
|---|---|
| Artificial intelligence (AI)-derived software to help clinical decision making in stroke | HealthTech guidance |
| Asundexian for preventing stroke after acute non-cardioembolic ischaemic stroke or high-risk transient ischaemic attack [GID-TA12033] | Technology appraisal guidance |
| Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source [ID1417] | Technology appraisal guidance |
| Invimestrocel for treating acute ischaemic stroke within 18 to 36 hours of onset [TSID10190] | Technology appraisal guidance |